Automated peritoneal dialysis - Recent aspects;Die automatisierte peritonealdialyse - Aktuelle klinische aspekte

Wiener Klinische Wochenschrift, Supplement

Volumn 117, Issue 6, 2005, Pages 98-108

  Vychytil, Andreas ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cycler; Peritonitis; Polyglucose; Residual renal function; Tidal peritoneal dialysis

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CA 125 ANTIGEN; CEFAZOLIN; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; DIALYSIS FLUID; GENTAMICIN; GLUCOSE POLYMER; NETILMICIN; VANCOMYCIN;

AUTOMATED PERITONEAL DIALYSIS; AUTOMATION; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; COST; DIALYSATE; DRUG ELIMINATION; EXTRACELLULAR FLUID; HUMAN; INJECTION PAIN; KIDNEY FAILURE; KIDNEY FUNCTION; METABOLIC ACIDOSIS; PERITONEAL DIALYSIS; PERITONITIS; QUALITY OF LIFE; REVIEW; ULTRAFILTRATION;

KIDNEY FAILURE, CHRONIC; PERITONEAL DIALYSIS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PROGNOSIS; TECHNOLOGY ASSESSMENT, BIOMEDICAL; THERAPY, COMPUTER-ASSISTED; TREATMENT OUTCOME;

EID: 32144443332     PISSN: 03005178     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00508-005-0496-7     Document Type: Review

References (86)

1. Hiroshige K, Yuu K, Soejima M, Takasugi M, Kuroiwa A (1996) Rapid decline of residual renal function in patients on automated peritoneal dialysis. Perit Dial Int 16: 307-315
2. Hufnagel G, Michel C, Queffeulou G, Skhiri H, Damieri H, Mignon F (1999) The influence of automated peritoneal dialysis on the decrease in residual renal function. Nephrol Dial Transplant 14: 1224-1228
3. Churchill DN, Taylor DW, Keshaviah PR, Thorpe KE, Beecroft ML, for the CANUSA Peritoneal Dialysis Study Group (1996) Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. J Am Soc Nephrol 7: 198-207
4. Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, et al (2002) Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 13: 1307-1320
5. Fenton SS, Schaubel DE, Desmeules M, Morrison HI, Mao Y, Copleston P, et al (1997) Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates. Am J Kidney Dis 30: 334-342
6. Collins AJ, Hao W, Xia H, Ebben JP, Everson SE, Constantini EG, et al (1999) Mortality risks of peritoneal dialysis and hemodialysis. Am J Kidney Dis 34: 1065-1074
7. Termorshuizen F, Korevaar JC, Dekker FW, Van Manen JG, Boeschoten EW, Krediet RT (2003) Hemodialysis and peritoneal dialysis: comparison of adjusted mortality rates according to the duration of dialysis: analysis of The Netherlands Cooperative Study on the Adequacy of Dialysis 2. J Am Soc Nephrol 14: 2851-2860
8. Woodrow G, Turney JH, Cook JA, Gibson J, Fletcher S, Stewart AJ, et al (1994) Nocturnal intermittent peritoneal dialysis. Nephrol Dial Transplant 9: 399-403
9. de Fijter CW, Oe LP, Nauta JJ, van der Meulen J, Verbrugh HA, Verhoef J, et al (1994) Clinical efficacy and morbidity associated with continuous cyclic compared with continuous ambulatory peritoneal dialysis. Ann Intern Med 120: 264-271
10. Heaf JG, Lokkegaard H, Madsen M (2002) Initial survival advantage of peritoneal dialysis relative to haemodialysis. Nephrol Dial Transplant 17: 112-117
11. Brown EA, Davies SJ, Rutherford P, Meeus F, Borras M, Riegel W, et al (2003) Survival of functionally anuric patients on automated peritoneal dialysis: the European APD Outcome Study. J Am Soc Nephrol 14: 2948-2957
12. Jager KJ, Merkus MP, Dekker FW, Boeschoten EW, Tijssen JG, Stevens P, et al (1999) Mortality and technique failure in patients starting chronic peritoneal dialysis: results of The Netherlands Cooperative Study on the Adequacy of Dialysis. NECOSAD Study Group. Kidney Int 55: 1476-1485
13. Guo A, Mujais S (2003) Patient and technique survival on peritoneal dialysis in the United States: evaluation in large incident cohorts. Kidney Int 64 [Suppl 88]: S3-S12
14. Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG, Page D (1998) Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 9: 1285-1292
15. Davies SJ, Phillips L, Griffiths AM, Russell LH, Naish PF, Russell GI (1998) What really happens to people on long-term peritoneal dialysis? Kidney Int 54: 2207-2217
16. Cueto-Manzano AM, Correa-Rotter R (2000) Is high peritoneal transport rate an independent risk factor for CAPD mortality? Kidney Int 57: 314-320
17. Hidaka H, Nakao T (2003) Preservation of residual renal function and factors affecting its decline in patients on peritoneal dialysis. Nephrology 8: 184-191
18. Singhal MK, Bhaskaran S, Vidgen E, Bargman JM, Vas SI, Oreopoulos DG (2000) Rate of decline of residual renal function in patients on continuous peritoneal dialysis and factors affecting it. Perit Dial Int 20: 429-438
19. Hamada C, Osada S, Inoue S, Tanaka A, Fukui M, Kubota M, et al (2000) Effects of automated peritoneal dialysis on residual urinary volume. Perit Dial Int 20: 239-241
20. Mujais S, Tebeau J, Harter M, Pu K (1998) Residual renal function in PD: impact of intermittency (Abstract). J Am Soc Nephrol 8: 286A
21. Holley JL, Aslam N, Bernardini J, Fried L, Piraino B (2001) The influence of demographic factors and modality on loss of residual renal function in incident peritoneal dialysis patients. Perit Dial Int 21: 302-305
22. Moist LM, Port FK, Orzol SM, Young EW, Ostbye T, Wolfe RA, et al (2000) Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol 11: 556-564
23. Rodríguez-Carmona A, Pérez-Fontán M, Garca-Naveiro R, Villaverde P, Peteiro J (2004) Compared time profiles of ultrafiltration, sodium removal, and renal function in incident CAPD and automated peritoneal dialysis patients. Am J Kidney Dis 44: 132-145
24. de Fijter CW, ter Wee PM, Donker AJ (2000) The influence of automated peritoneal dialysis on the decrease in residual renal function. Nephrol Dial Transplant 15: 1094-1096
25. Rodríguez-Carmona A, Pérez Fontán M, García Falcón T, Fernández Rivera C, Valdés F (1999) A comparative analysis on the incidence of peritonitis and exit-site infection in CAPD and automated peritoneal dialysis. Perit Dial Int 19: 253-258
26. Diaz-Buxo JA, Crawford TL, Bailie GR (2001) Peritonitis in automated peritoneal dialysis: antibiotic therapy and pharmacokinetics. Perit Dial Int 21 [Suppl 3]: S197-S201
27. Bro S, Bjorner JB, Tofte-Jensen P, Klem S, Almtoft B, Danielsen H, et al (1999) A prospective, randomized multicenter study comparing APD and CAPD treatment. Perit Dial Int 19: 526-533
28. de Fijter CW, Verbrugh HA, Oe LP, Peters ED, van der Meulen J, Donker AJ, et al (1992) Peritoneal defense in continuous ambulatory versus continuous cyclic peritoneal dialysis. Kidney Int 42: 947-950
29. Locatelli AJ, Marcos GM, Gomez MG, Alvarez SA, De-Benedetti LC (1999) Comparing peritonitis in continuous ambulatory peritoneal dialysis patients versus automated peritoneal dialysis patients. Adv Perit Dial 15: 193-196
30. Holley JL, Bernardini J, Piraino B (1990) Continuous cycling peritoneal dialysis is associated with lower rates of catheter infections than continuous ambulatory peritoneal dialysis. Am J Kidney Dis 16: 133-136
31. Piraino B, Bailie GR, Bernardini J, Boeschoten E, Gupta A, Holmes C, et al (2005) Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int 25: 107-131
32. Kiernan L, Kliger A, Gorban-Brennan N, Juergensen P, Tesin D, Vonesh E, et al (1995) Comparison of continuous ambulatory peritoneal dialysis-related infections with different "Y-tubing" exchange systems. J Am Soc Nephrol 5: 1835-1838
33. Gahrmani N, Gorban-Brennan N, Kliger AS, Finkelstein FO (1995) Infection rates in end-stage renal disease patients treated with CCPD and CAPD using the UltraBag system. Adv Perit Dial 11: 164-167
34. Troidle LK, Gorban-Brennan N, Kliger AS, Finkelstein FO (1998) Continuous cycler therapy, manual peritoneal dialysis therapy, and peritonitis. Adv Perit Dial 14: 137-141
35. Yishak A, Bernardini J, Fried L, Piraino B (2001) The outcome of peritonitis in patients on automated peritoneal dialysis. Adv Perit Dial 17: 205-208
36. Huang JW, Hung KY, Yen CJ, Wu KD, Tsai TJ (2001) Comparison of infectious complications in peritoneal dialysis patients using either a twin-bag system or automated peritoneal dialysis. Nephrol Dial Transplant 16: 604-607
37. Basile C, De Padova F (2001) Comparison of peritonitis incidence in CAPD and automated peritoneal dialysis. Nephrol Dial Transplant 16: 1957-1958
38. Kavanagh D, Prescott GJ, Mactier RA (2004) Peritoneal dialysis-associated peritonitis in Scotland (1999-2002). Nephrol Dial Transplant 19: 2584-2591
39. Oo TN, Roberts TL, Collins AJ (2005) A comparison of peritonitis rates from the United States Renal Data System database: CAPD versus continuous cycling peritoneal dialysis patients. Am J Kidney Dis 45: 372-380
40. Holley JL, Bernardini J, Piraino B (1994) Infecting organisms in continuous ambulatory peritoneal dialysis patients on the Y-set. Am J Kidney Dis 23: 569-573
41. Burkart JM, Jordan JR, Durnell TA, Case LD (1992) Comparison of exit-site infections in disconnect versus nondisconnect systems for peritoneal dialysis. Perit Dial Int 12: 317-320
42. Stea S, Bachelor T, Cooper M, de Souza P, Koenig K, Bolton WK (1996) Disposition and bioavailability of ceftazidime after intraperitoneal administration in patients receiving continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 7: 2399-2402
43. Manley HJ, Bailie GR, Asher RD, Eisele G, Frye RF (1999) Pharmacokinetics of intermittent intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients. Peril Dial Int 19: 65-70
44. Vas S, Bargman J, Oreopoulos D (1997) Treatment in PD patients of peritonitis caused by gram-positive organisms with single daily dose of antibiotics. Perit Dial Int 17: 91-94
45. Lai MN, Kao MT, Chen CC, Cheung SY, Chung WK (1997) Intraperitoneal once-daily dose of cefazolin and gentamicin for treating CAPD peritonitis. Perit Dial Int 17: 87-89
46. Goldberg L, Clemenger M, Azadian B, Brown EA (2001) Initial treatment of peritoneal dialysis peritonitis without vancomycin with a once-daily cefazolin-based regimen. Am J Kidney Dis 37: 49-55
47. Manley HJ, Bailie GR (2002) Treatment of peritonitis in APD: pharmacokinetic principles. Semin Dial 15: 418-421
48. Manley HJ, Bailie GR, Frye R, Hess LD, McGoldrick MD (2000) Pharmacokinetics of intermittent intravenous cefazolin and tobramycin in patients treated with automated peritoneal dialysis. J Am Soc Nephrol 11: 1310-1316
49. Manley HJ, Bailie GR, Frye R, McGoldrick MD (2000) Intermittent intravenous piperacillin pharmacokinetics in automated peritoneal dialysis patients. Perit Dial Int 20: 686-693
50. Manley HJ, Bailie GR, Frye RF, McGoldrick MD (2001) Intravenous vancomycin pharmacokinetics in automated peritoneal dialysis patients. Perit Dial Int 21: 378-385
51. Fielding RE, Clemenger M, Goldberg L, Brown EA (2002) Treatment and outcome of peritonitis in automated peritoneal dialysis, using a once-daily cefazolin-based regimen. Perit Dial Int 22: 345-349
52. De Vecchi AF, Scalamogna A, Finazzi S, Colucci P, Ponticelli C (2000) Preliminary evaluation of incremental peritoneal dialysis in 25 patients. Perit Dial Int 20: 412-148
53. Twardowski ZJ, Prowant BF, Nolph KD, Khanna R, Schmidt LM, Satalowich RJ (1990) Chronic nightly tidal peritoneal dialysis. ASAIO Trans 36: M584-M588
54. Piraino B, Bender F, Bernardini J (1994) A comparison of clearances on tidal peritoneal dialysis and intermittent peritoneal dialysis. Perit Dial Int 14: 145-148
55. Vychytil A, Lilaj T, Schneider B, Hörl WH, Haag-Weber M (1999) Tidal peritoneal dialysis for home-treated patients: should it be preferred? Am J Kidney Dis 33: 334-343
56. Juergensen PH, Murphy AL, Pherson KA, Kliger AS, Finkelstein FO (2000) Tidal peritoneal dialysis: comparison of different tidal regimens and automated peritoneal dialysis. Kidney Int 57: 2603-2607
57. Juergensen PH, Murphy AL, Pherson KA, Chorney WS, Kliger AS, Finkelstein FO (1999) Tidal peritoneal dialysis to achieve comfort in chronic peritoneal dialysis patients. Adv Perit Dial 15: 125-126
58. Holtta T, Ronnholm K, Holmberg C (2000) Adequacy of dialysis with tidal and continuous cycling peritoneal dialysis in children. Nephrol Dial Transplant 15: 1438-1442
59. Neri L, Viglino G, Cappelletti A, Gandolfo C, Barbieri S (2002) Compliance in automated peritoneal dialysis. Adv Perit Dial 18: 72-74
60. Bernardini J, Piraino B (1998) Compliance in CAPD and CCPD patients as measured by supply inventories during home visits. Am J Kidney Dis 31: 101-107
61. Bernardini J, Nagy M, Piraino B (2000) Pattern of non-compliance with dialysis exchanges in peritoneal dialysis patients. Am J Kidney Dis 35: 1104-1110
62. Raj DS (2002) Role of APD in compliance with therapy. Semin Dial 15: 434-436
63. Shinaberger JH, Shear L, Barry KG (1965) Increasing efficiency of peritoneal dialysis: experience with peritoneal-extracorporeal recirculation dialysis. Trans Am Soc Artif Intern Organs 11: 76-82
64. Ronco C, Gloukhoff A, Dell'Aquila R, Levin NW (2002) Catheter design for continuous flow peritoneal dialysis. Blood Purif 20: 40-44
65. Diaz-Buxo JA (2005) Access and continuous flow peritoneal dialysis. Perit Dial Int 25 [Suppl 3]: S102-S104
66. Stephen RL, Atkin-Thor E, Kolff WJ (1976) Recirculating peritoneal dialysis with subcutaneous catheter. Trans Am Soc Artif Intern Organs 22: 575-585
67. Mineshima M, Suzuki S, Sato Y, Ishimori I, Ishida K, Kaneko I, et al (2000) Solute removal characteristics of continuous recirculating peritoneal dialysis in experimental and clinical studies. ASAIO J 46: 95-98
68. Raj DS, Self M, Work J (2000) Hybrid dialysis: recirculation peritoneal dialysis revisited. Am J Kidney Dis 36: 58-67
69. Passlick-Deetjen J, Quellhorst E (2001) Continuous flow peritoneal dialysis (CFPD): a glimpse into the future. Nephrol Dial Transplant 16: 2296-2299
70. Diaz-Buxo JA (2001) Continuous flow peritoneal dialysis. Nephrol News Issues 15: 18-21
71. Diaz-Buxo JA (2002) Continuous flow peritoneal dialysis: clinical applications. Blood Purif 20: 36-39
72. Freida P, Issad B (2003) Continuous flow peritoneal dialysis: assessment of fluid and solute removal in a high-flow model of "fresh dialysate single pass". Perit Dial Int 23: 348-355
73. Ronco C, Dell'Aquila R, Bonello M, Gloukhoff A, Amerling R, Cruz C, et al (2003) Continuous flow peritoneal dialysis: a new double lumen catheter. Int J Artif Organs 26: 984-990
74. Diaz-Buxo JA (2004) Continuous-flow peritoneal dialysis: update. Adv Perit Dial 20: 18-22
75. Woodrow G, Stables G, Oldroyd B, Gibson J, Turney JH, Brownjohn AM (1999) Comparison of icodextrin and glucose solutions for the daytime dwell in automated peritoneal dialysis. Nephrol Dial Transplant 14: 1530-1535
76. Plum J, Gentile S, Verger C, Brunkhorst R, Bahner U, Faller B, et al (2002) Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis. Am J Kidney Dis 39: 862-871
77. Davies SJ, Woodrow G, Donovan K, Plum J, Williams P, Johansson AC, et al (2003) Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial. J Am Soc Nephrol 14: 2338-2344
78. Davies SJ, Brown EA, Frandsen NE, Rodrigues AS, Rodriguez-Carmona A, Vychytil A, et al (2005) Longitudinal membrane function in functionally anuric patients treated with APD: data from EAPOS on the effects of glucose and icodextrin prescription. Kidney Int 67: 1609-1615
79. Delarue J, Maingourd C, Objois M, Pinault M, Cohen R, Couet C, et al (1999) Effects of an amino acid dialysate on leucine metabolism in continuous ambulatory peritoneal dialysis patients. Kidney Int 56: 1934-1943
80. Garibotto G, Sofia A, Canepa A, Saffioti S, Sacco P, Sala M, et al (2001) Acute effects of peritoneal dialysis with dialysates containing dextrose or dextrose and amino acids on muscle protein turnover in patients with chronic renal failure. J Am Soc Nephrol 12: 557-567
81. Tjiong HL, van den Berg JW, Wattimena JL, Rietveld T, van Dijk LJ, van der Wiel AM, et al (2005) Dialysate as food: combined amino acid and glucose dialysate improves protein anabolism in renal failure patients on automated peritoneal dialysis. J Am Soc Nephrol 16: 1486-1493
82. Brunkhorst R, Fromm S, Wrenger E, Berke A, Petersen R, Riede G, et al (1998) Automated peritoneal dialysis with 'on-line'-prepared bicarbonate-buffered dialysate: technique and first clinical experiences. Nephrol Dial Transplant 13: 3189-3192
83. Dratwa M, Wilkie M, Ryckelynck JP, ter Wee PM, Rutherford P, Michel C, et al (2003) Clinical experience with two physiologic bicarbonate/lactate peritoneal dialysis solutions in automated peritoneal dialysis. Kidney Int 64 [Suppl 88]: S105-S113
84. Van de Walle JG, Raes AM, Dehoorne J, Mauel R (2004) Use of bicarbonate/lactate-buffered dialysate with a night-time cycler, associated with a daytime dwell with icodextrin, may result in alkalosis in children. Adv Perit Dial 20: 222-225
85. Haas S, Schmitt CP, Arbeiter K, Bonzel KE, Fischbach M, John U, et al (2003) Improved acidosis correction and recovery of mesothelial cell mass with neutral-pH bicarbonate dialysis solution among children undergoing automated peritoneal dialysis. J Am Soc Nephrol 14: 2632-2638
86. Fusshoeller A, Plail M, Grabensee B, Plum J (2004) Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD: a prospective, randomized study. Nephrol Dial Transplant 19: 2101-2106